Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia

By Polillo Marialuisa   Galimberti Sara   Baratè Claudia   Petrini Mario   Danesi Romano   Di Paolo Antonello  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 22811-22829

MDPI

Access to resources Recommend Favorite

Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment

By Gbolahan Olumide Babajide   Zeidan Amer M.   Stahl Maximilian   Abu Zaid Mohammad   Farag Sherif   Paczesny Sophie   Konig Heiko  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-07 ,pp. : 1660-1660

MDPI

Access to resources Recommend Favorite

Antiproliferative Effect of Aaptamine on Human Chronic Myeloid Leukemia K562 Cells

By Jin Meihua   Zhao Wennan   Zhang Yanwen   Kobayashi Motomasa   Duan Hongquan   Kong Dexin  

International Journal of Molecular Sciences, Vol. 12, Iss. 11, 2011-10 ,pp. : 7352-7359

MDPI

Access to resources Recommend Favorite

DNA Repair—A Double-Edged Sword in the Genomic Stability of Cancer Cells—The Case of Chronic Myeloid Leukemia

By Pawlowska Elzbieta   Blasiak Janusz  

International Journal of Molecular Sciences, Vol. 16, Iss. 11, 2015-11 ,pp. : 27535-27549

MDPI

Access to resources Recommend Favorite

Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells

By Liu Juan   Zhang Yujing   Liu Aichun   Wang Jinghua   Li Lianqiao   Chen Xi   Gao Xinyu   Xue Yanming   Zhang Xiaomin   Liu Yao  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 531-531

MDPI

Access to resources Recommend Favorite